Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Xencor, Inc.
Xencor, Inc.
University Hospital, Clermont-Ferrand
University College Cork
Kaiser Permanente
Context Therapeutics Inc.
Indiana University
University of Arizona
BioNTech SE
Indiana University
Jonsson Comprehensive Cancer Center
Loma Linda University
City of Hope Medical Center
Swiss Cancer Institute
St. Olavs Hospital
University Medical Center Groningen
West China Hospital
UNC Lineberger Comprehensive Cancer Center
University of Arizona
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
Western University, Canada
BioNTech SE
Columbia University
University of California, Irvine
University Health Network, Toronto
City of Hope Medical Center